MedPath

The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients

Not Applicable
Completed
Conditions
Leprosy
Interventions
Procedure: Routine treatment
Radiation: Low level laser therapy (LLLT)
Registration Number
NCT00860717
Lead Sponsor
Para Federal University
Brief Summary

Neuropathic ulcers are common sequelae of leprosy. The objectives of this study are to analyze the clinic-epidemiological characteristics of patients attended at one specialized dressing service from a leprosy-endemic region of the Brazilian Amazon and to evaluate the effect of Low Level Laser Therapy on wound healing of these patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • presented with neuropathic ulcer
  • attended at least 3 weekly appointments at the dressing service of UREMC
  • completed specific multi-drug therapy for M. leprae
  • gave written informed consent to participate in the study
Exclusion Criteria
  • clinically detectable infection in the ulcer
  • use of drugs, like corticosteroids that could interfere with the wound healing process
  • use of special dressings like hydrocolloid, calcium alginate, activated carbon or any kind of therapeutic procedure different from that used routinely for both groups of study
  • non-attendance to therapeutic program (six sequential times or nine intercalated)
  • pregnancy
  • discomfort during treatment procedure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Routine treatmentSubjects from the arm number 1 received routine treatment, including daily simple dressings with sterile gauze after wound cleaning with a 0.9% physiologic solution, use of 1% hydrophilic silver sulfadiazine cream (Prati Donaduzzi Laboratory, Toledo, Brazil) and orientation about the use of adapted footwear, self-care and the prevention of disabilities. Surgical debridement was done whenever indicated by nursing or orthopedic services from UREMC.
2Low level laser therapy (LLLT)Subjects from the arm number 2 received low level laser therapy 3 times per week for 12 weeks, in addition to the same treatment as patients from the arm number 1.
Primary Outcome Measures
NameTimeMethod
Wound healingBiweekly until the end of the 12 week treatment period.
Secondary Outcome Measures
NameTimeMethod
Ulcer surface area, depth and PUSH tool score.Biweekly until the end of the 12 week treatment period or until complete cicatrization of the treated ulcer.

Trial Locations

Locations (1)

Dr. Marcello Candia Reference Unit in Sanitary Dermatology of the State of Pará in Brazil (UREMC)

🇧🇷

Marituba, Pará, Brazil

© Copyright 2025. All Rights Reserved by MedPath